in view of encouraging results from various reliable multicenter studies , an interesting new oral agent , auranofin ( triethylphosphine gold ) , is believed to be a major advance towards more effective treatment of rheumatoid arthritis with mild adverse reactions .
C0004320
auranofin
C0003873
rheumatoid arthritis